Neogen (NEOG) Aktsia Kursus

Neogen Kursus

NASDAQ·SULETUD
11,97
​
Turg suletud

Viimase 19 aasta jooksul kasvas Neogen käive 12,9 % aastas ja jõudis 870,40 M USD-ni. Kasum aktsia kohta kasvas 5,2 % aastas viimase 15 aasta jooksul. Neogen netomarginaal −0,9 % on langenud võrreldes 9,2 %-ga mõni aasta tagasi. Neogen 12 kuu konsensuse hinnasiht on 13,00 USD, umbes üle kurssi 8,6 %. 11 analüütikust 8 soovitab osta — üldine konsensus on Osta.

Neogen aktsiahinnad

Hangi need andmed Eulerpool API kaudu

100 000 päringut/kuus tasuta · krediitkaarti pole

Neogen ärimudel ja aktsia analüüs

Neogen Corp on USA Michigani Lansingis asuv juhtiv toiduohutuse ja loomade tervishoiu lahenduste pakkuja. Ettevõtte asutas 1982. aastal James Herbert ja selle algne tegevuskeskpunkt oli piimandustööstuse kiiretestide arendamine ja tootmine. Alates sellest ajast on Neogenist saanud rahvusvaheliselt tegutsev ettevõte, millel on üle 25 filiaali ja 1 800 töötajat. Neogeni ärimudel põhineb lahenduste pakkumisel ohutu ja tervisliku toiduhälmistuse ning loomakasvatuse tagamiseks. Ettevõte tegutseb kahes peamises segmendis: Toiduohutus ja Loomade tervishoid. Nende segmentide raames pakub Neogen laias valikus testkomplekte, diagnostikavahendeid, infohalduse tarkvara ja muid tooteid, mis aitavad minimeerida toidumürgistuse riski ja parandada kariloomade tervist. Toiduohutuse segmendis pakub Neogen erinevaid testkomplekte, mis võimaldavad toidutootjatel ja jaemüüjadel kiiresti ja lihtsalt tuvastada toidus erinevaid saasteaineid. Nende hulka kuuluvad testid salmonella, E. coli, listeria ja mükotoksiinide jaoks. Ettevõte pakub ka vahendeid veekvaliteedi jälgimiseks ning puhastus- ja desinfitseerimisprotsesside kinnitamiseks toidutöötlemistehastes. Loomade tervishoiu segmendis pakub Neogen samuti ulatuslikku valikut diagnostikavahendeid kariloomade tervise parandamiseks. Testid hõlmavad nakkushaigusi, nagu brutselloos, BSE (lehmamahla tõbi), mastiit ja leukeemia. Lisaks pakub Neogen vahendeid loomade identifitseerimiseks ja loomatervise andmete haldamiseks. Neogen on spetsialiseerunud ka tehnoloogiate arendamisele loomade tervise ja toitumise parandamiseks, näiteks probiootikumide ja lisandite tootmisele kariloomadele. Teine Neogeni fookus on infohalduse tarkvara arendamisel, mis võimaldab toidutootjatel ja jaemüüjail lihtsustada toiduohutuse ja kvaliteedi protsesse. Tarkvara võimaldab ettevõtetel jälgida teste, analüüsida andmeid ja rakendada parimaid tavasid toidumürgistuse riski minimeerimiseks. Viimasel ajal on Neogen suurendanud oma fookust globaalsel turul, eriti Aasia turul. Ettevõttel on filiaale üle maailma, sealhulgas Euroopas, Ladina-Ameerikas ja Aasias. Neogen teeb koostööd kohalike regulatiivsete asutustega, et pakkuda oma tooteid vastavalt kohalikele nõuetele. Kokkuvõtvalt on Neogen Corp juhtiv toiduohutuse ja loomade tervishoiu lahenduste pakkuja, keskendudes testikomplektide, diagnostikavahendite ja infohalduse tarkvara arendamisele ning tootmisele. Ettevõte on viimastel kümnenditel kogunud muljetavaldavat kasvu ja tegutseb nüüd rahvusvaheliselt. Pühendumise ohutu ja tervisliku toiduhälmistuse ning loomakasvatuse tagamiseks seab Neogen tööstuses standardid.

Korduma kippuvad küsimused Neogen aktsia kohta

Neogen Corp is a leading company in the field of food and animal safety. Their business model revolves around providing diagnostic solutions and expertise to various industries. They offer a wide range of products and services including food safety testing, animal health products, and genomic testing. Neogen Corp utilizes advanced technologies and innovations to ensure the quality and safety of the food supply chain, prevent diseases in animals, and improve overall agricultural productivity. With a strong focus on research and development, Neogen Corp continuously delivers reliable and sustainable solutions to meet the evolving needs of their customers worldwide.

Neogen Corp is primarily active in the food safety and animal health industries.

The main competitors of Neogen Corp in the market include companies such as IDEXX Laboratories, Zoetis Inc., and Thermo Fisher Scientific Inc.

Neogen Corp, founded in 1982, is a leading global company specializing in food and animal safety solutions. Headquartered in Lansing, Michigan, Neogen is committed to developing innovative products for the agricultural, food, and pharmaceutical industries. With a diverse range of products and services, Neogen offers reliable and accurate diagnostic test kits, hygiene monitoring systems, and animal genomics solutions. They have built a solid reputation for their commitment to quality, customer service, and staying at the forefront of technological advancements. Neogen Corp's continuous dedication to improving food safety and animal health has made them a trusted and respected name in the industry.

Neogen Corp has achieved several significant milestones throughout its history. The company successfully developed and introduced rapid food and animal safety tests, revolutionizing the industry. They expanded their product portfolio to include diagnostics for human healthcare, veterinary medicine, and agricultural concerns globally. Neogen Corp's continuous innovations in genomics, biosecurity, and animal safety further propelled its growth. The company established strategic partnerships and collaborations to enhance its product offerings and market reach. Neogen Corp's commitment to quality, accuracy, and reliability has earned them a strong reputation with customers worldwide. With a track record of achievements, Neogen Corp continues to lead as a trusted provider of innovative solutions in the field of food and animal safety.

Neogen Corp is primarily present in several countries and regions around the world. These include the United States, Canada, Mexico, and various countries in Europe, such as Belgium, France, Germany, and the United Kingdom. Additionally, Neogen Corp has a strong presence in Asia, with operations in China and southeast Asian countries like Singapore. With its global reach, Neogen Corp continues to expand its presence and offer its innovative products and services to customers in diverse markets.

Neogen Corp is a company that values innovation, integrity, and commitment to quality. Their corporate philosophy revolves around providing solutions for the food and animal safety industries through advanced technology and dedicated research. With a focus on developing and marketing products to ensure the safety of food, feed, and animal health, Neogen Corp aims to be a trusted partner for agricultural, veterinary, and food processing industries. By consistently delivering high-quality products and services, Neogen Corp reinforces its commitment to the safety and well-being of both humans and animals, making it a reputable player in the industry.

Analüütikud määravad Neogen aktsiale keskmiseks hinnasihi 13,00 USD (mediaan: 13,00 USD), mis on +8,6 % viimase hinna suhtes. Konsensus põhineb 11 analüütiku hinnangul.

11 analüütikut hindavad praegu Neogen aktsiat: 8 soovitab osta, 3 hoida ja 0 müüa.

Praeguse kursiga kaubeldakse Neogen aktsiaga 10,65 EUR (11,97 USD) juures.

Neogen aktsia (NEOG) on noteeritud 2 börsil, sh: NASDAQ (NEOG), Frankfurt (NG2.F).

The company Neogen Corp is a leading provider of food and animal health products. Its business model is focused on developing high-quality products and services that help improve food and animal health. The company is divided into two main areas: food and animal health. In the food sector, Neogen offers testing systems and diagnostic products that are used to monitor food safety and quality. Neogen's testing systems are used in food technology, animal feed control, and animal health. The products range from allergen-specific tests to detection methods for contamination or spoilage in food. In the animal health segment, the company offers a wide range of therapeutic and preventive products to promote animal health and performance. The product range includes products for the diagnosis and treatment of animals as well as medications, feed additives, and other products. Neogen Corp also offers services such as laboratory services and training. Neogen focuses on innovation and regularly invests in research and product development. The company works closely with leading universities and institutes to develop innovative products that meet the needs of customers. Product development focuses on creating effective solutions for animal health, preventing food contamination, and improving food quality. The company operates internationally and offers its products and services worldwide. Neogen has subsidiaries in Europe, Asia, and South America and works with distributors in over 60 countries. Neogen's global presence enables the company to meet the diverse needs of its customers in different countries and regions. In addition to its business activities, Neogen emphasizes its commitment to sustainability and social responsibility. The company is dedicated to promoting environmental and food quality, as well as the safety and health of animals. It also works to develop and improve its products and services to promote these goals. Neogen Corp is a leading provider of food and animal health products. The company offers a wide range of products and services aimed at improving food and animal health standards. The company relies on innovation and investments in research and development to create high-quality solutions for customers around the world. With a strong global presence and a commitment to sustainability and social responsibility, Neogen is well positioned to drive growth in these critical areas of the economy.

Neogen käive on 870,40 M USD. See näitaja põhineb praegusel finantsandmetel ja peegeldab ettevõtte äritulemuseid.

Neogen kasum on −7,90 M USD. Netokasum peegeldab ettevõtte kasumlikkust pärast kõigi kulude mahaarvamist.

Võrdlusarvud hinna ja kasumiga (P/E) Neogen jaoks on praegu −330,46. P/E-suhtarv võrdleb praegust aktsiahinnad kasumiga aktsia kohta ja aitab investoritel hinnata Neogen aktsia väärtust.

Kursuse ja müügimahu suhe (P/S) Neogen jaoks on praegu 3,00. P/S-suhtarv võrdleb börsikapitalisatsooni aastase tuluga ja teenib hindamismõõdikuna Neogen aktsia jaoks.

Eulpooli kvaliteedinäitaja Neogen jaoks on 2/10.

Neogen ISIN on US6404911066. ISIN (rahvusvaheline väärtpaberi identifitseerimise number) on väärtpaberite globaalne unikaalne tuvastaja.

Neogen WKN on 883297. WKN (Wertpapierkennnummer) on kuuekohaline saksa väärtpaberi identifitseerimise number.

Neogen ticker on NEOG. Ticker-sümbol kasutatakse Neogen aktsiate kauplemiseks börsil.

Õiglane väärtusTerminal
12,09 USD
Üle-/alahinnangTerminal
Õiglaselt hinnatakse
Tööstus
Tervishoiuvarustus ja tarvikud
Aktsiate arv
Töötajad
Tulu töötaja kohta
330 197,27 USD
Tulukasvu keskmine 5 aastat
EBIT kasvu keskmine 5 aastat
Puhaskasumi kasvu keskmine 5 aastat
Veebisait neogen.com
Valuuta
USD
Börsi noteerimise algus
23. aug 1989
ISIN
US6404911066
CUSIP
640491106
SEDOL
2630085
Turukapitalisatsioon
2,60 B USDMid Cap
52-nädala vahemik
PEG
−27,30
P/E suhe
P/E e 2027
39,25
P/E e 2028
28,73
P/E e 2029
23,02
P/E e 2030
23,94
P/E e 2031
22,17
P/S
P/S e
2,95
EV/EBIT
—
P/B suhe
1,24
ROE (omakapitali tootlus)
ROA (varatootlus)
ROCE (kasutatud kapitali tootlus)
ROIC (investeeritud kapitali tootlus)
−0,27 %
Viimati värskendatud 18. okt 2026, 00:30

Neogen Börsiticker

FRANKFURT · NG2.FNASDAQ · NEOG

Neogen FIGI

NEOG:US · BBG000C1BCK2NEOG:UA · BBG000C1BCR5NEOG:UC · BBG000C1BD57NEOG:UN · BBG000C1BFF1NEOG:UP · BBG000C1BFR8NEOG:UB · BBG000C1BGV1NEOG:UM · BBG000C1BJN4NEOG:UX · BBG000C1BKL3NEOG:UD · BBG000C1BMJ2NEOG:UW · BBG000C1BPB3NEOG:UF · BBG000C1BPX9NEOG:VY · BBG000C1BQ94

Kõik teised näitajad ja analüüsid Neogen kohta sügavamalt

Meie Neogen-aktsia analüüs sisaldab olulisi finantsnäitajaid, nagu käive, kasum, P/E suhe, P/S suhe, EBIT, samuti teavet dividendi kohta. Lisaks käsitleme aspekte nagu aktsiad, turukapitalisatsioon, võlad, omakapital ja kohustused ettevõttes Neogen. Kui otsite nende teemade kohta põhjalikumat teavet, pakume teile meie alamlehtedel üksikasjalikke analüüse: